English
|
Spanish
Login
Register
The content on this site is intended for healthcare professionals only
For the latest
e
cancer COVID-19 resources, click on this link
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
News
e
cancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.
Latest news
Category
All
Disease Areas
Patient Care
Policy
Prevention & screening
Treatments
Sub-category
All
Conference
All
EHA Congress 2022
ASCO 2022
AACR Annual Meeting 2022
2022 Genitourinary Cancers Symposium
ASCO GI 2022
ASH 2021
SABCS 2021
ESMO 2021
AUA 2021
WCLC 2021
EAU21
ESMO World Congress on Gastrointestinal Cancer 2021
EHA 2021
ASCO 2021
AACR 2021
ELCC 2021
2021 Genitourinary Cancers Symposium
WCLC 2020
SABCS 2020
ASH 2020
32th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics
EBCC-12 European Breast Cancer Conference
ESMO 2020
EHA 2020
ASCO 2020
AACR 2020
ecancer COVID-19 Resources
COVID-19 Recursos
SABCS 2019
ASH 2019
ESMO 2019
Year
All
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Keyword
ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cance...
Bridge therapy may benefit some children with high-risk neuroblastoma
ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric lo...
ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagno...
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic col...
ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast canc...
ASCO 2022: High-dose ifosfamide demonstrated as a standard of care for recurrent and primary refract...
ASCO 2022: Lung cancer therapy could help patients live longer
ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein
1
...
5
6
7
8
9
...
1821
Tweets by @ecancer
More from
e
cancer